- Home
- / Acumen Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Acumen Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.9
2024-10-29
Market Capitalization
$174.5 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| General and administrative expense | 7.3M | 12.9M | 18.8M | 20.2M | 18.9M |
| Operating expense total | 45.2M | 114.0M | 123.8M | ||
| EBIT | (19.6M) | (45.2M) | (61.1M) | (114.0M) | (123.8M) |
| Interest income | 10.8M | 14.3M | 7.4M | ||
| Interest expense | 84.0K | 2.4M | 581.0K | 3.0M | |
| Net Income | (100.6M) | (42.9M) | (52.4M) | (102.3M) | (121.3M) |
| EPS | (1.1) | (1.0) | (1.7) | (2.0) |